Literature DB >> 10334364

Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.

G E Mannor1, G E Rose, K Frimpong-Ansah, E Ezra.   

Abstract

PURPOSE: To ascertain the effect of certain parameters on nasolacrimal duct probing.
METHODS: In a retrospective study of 142 infants and children who underwent nasolacrimal duct probing for congenital nasolacrimal duct obstruction, age at time of probing, gender, symptom severity, presence of mucous discharge, and history of probing were correlated with success of nasolacrimal probing. Success of probing was defined as complete resolution of signs and symptoms of nasolacrimal duct obstruction. Chi-square test was used to analyze covariance.
RESULTS: Success of nasolacrimal duct probing was negatively correlated with increasing age: 92%, 89%, 80%, 71%, and 42% at age 12, 24, 36, 48, and 60 months, respectively (P = .001 at each interval). Increasing severity of epiphora was correlated with increased failure of nasolacrimal duct probing (P = .05).
CONCLUSIONS: Although the success of nasolacrimal duct probing declines with age, probing in older children can remain the first line of treatment. Because increasing frequency of epiphora correlates with failure of nasolacrimal duct probing, children with daily epiphora should undergo early nasolacrimal duct probing.

Entities:  

Mesh:

Year:  1999        PMID: 10334364     DOI: 10.1016/s0002-9394(98)00432-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  Management of childhood epiphora.

Authors:  J E Marr; A Drake-Lee; H E Willshaw
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Long-term results of probing guided with soft cannula in children with congenital nasolacrimal duct obstruction.

Authors:  Dilek Yuksel; Pınar Altiaylik Ozer
Journal:  Jpn J Ophthalmol       Date:  2013-11-16       Impact factor: 2.447

3.  Balloon dacryoplasty: ushering the new and routine era in minimally invasive lacrimal surgeries.

Authors:  Mohammad Javed Ali; Milind N Naik; Santosh G Honavar
Journal:  Int Ophthalmol       Date:  2012-10-17       Impact factor: 2.031

4.  Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.

Authors:  Deok Sun Cha; Hwa Lee; Min Soo Park; Jong Mi Lee; Se Hyun Baek
Journal:  Korean J Ophthalmol       Date:  2010-10-05

5.  Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.

Authors:  Masahiro Fujimoto; Ken Ogino; Hiroko Matsuyama; Chika Miyazaki
Journal:  Jpn J Ophthalmol       Date:  2016-04-27       Impact factor: 2.447

6.  Probing for congenital nasolacrimal duct obstruction in older children.

Authors:  Bahram Eshragi; Masoud Aghsaei Fard; Babak Masomian; Mohammadreza Akbari
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

7.  Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.

Authors:  Michael X Repka; Danielle L Chandler; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Katherine Lee; Michele Melia; Graham E Quinn; Nick A Sala; Susan Schloff; David I Silbert; David K Wallace
Journal:  Ophthalmology       Date:  2007-11-08       Impact factor: 12.079

8.  The course of epiphora after failure of silicone intubation for congenital nasolacrimal duct obstruction.

Authors:  Yanir Kassif; Uri Rehany; Michal David; Anna Popko; Shimon Rumelt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

9.  Acquired nasolacrimal duct obstruction in children.

Authors:  Kyu Mee Kay; Kyung In Woo; Jung Hoon Kim; Hae Ran Chang
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

10.  The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age.

Authors:  Hirohiko Kakizaki; Yasuhiro Takahashi; Shinsuke Kinoshita; Kunihiko Shiraki; Masayoshi Iwaki
Journal:  Clin Ophthalmol       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.